文献速递胸部肿瘤放疗放疗物理与技术

蝴蝶形容积旋转调强放疗与全弧容积旋转调强放疗加或不加深吸气屏气治疗纵隔淋巴瘤的比较

Comparison of butterfly volumetric modulated arc therapy to full arc with or without deep inspiration breath hold for the treatment of mediastinal lymphoma.
PubMed 文献 · Radiother Oncol · 2018-09-21

本研究对20例纵隔淋巴瘤患者(15例女性)在自由呼吸和深吸气屏气扫描上分别计算全弧容积旋转调强放疗(F-VMAT)与限角蝴蝶形容积旋转调强放疗(B-VMAT)计划,比较剂量学差异。结果显示B-VMAT显著降低低肺剂量而F-VMAT在高肺剂量区更优,深吸气屏气进一步改善肺剂量,两者对部分参数获益相加、对其他参数互补。

要点

  • B-VMAT显著降低低肺剂量(V5-10),F-VMAT在高肺剂量(V20-30)更优。
  • 深吸气屏气进一步改善两种计划的肺剂量,B-VMAT联合深吸气屏气平均肺剂量最低。
  • 自由呼吸时B-VMAT心脏剂量略高但差异小,深吸气屏气显著降低心脏剂量。

核心结论

  • B-VMAT与深吸气屏气均能有效降低器官剂量,剂量学获益对部分参数为相加、对其他参数为互补。

研究设计与样本

  • 对20例连续纵隔淋巴瘤患者(15例女性)在自由呼吸和深吸气屏气CT扫描上分别计算F-VMAT与B-VMAT计划,计划靶区V95%保持可比并尽可能降低器官剂量。

主要发现

  • B-VMAT显著降低低肺剂量(V5-10),而F-VMAT在高肺剂量(V20-30)更优。
  • 深吸气屏气进一步改善两种计划的肺剂量,深吸气屏气联合B-VMAT产生最低的平均肺剂量。
  • 自由呼吸时B-VMAT心脏剂量略高,最大差异小(V20为0.8%)且仅V10-20有统计学显著性,平均心脏剂量仅增加0.1 Gy。
  • 深吸气屏气显著降低心脏剂量,深吸气屏气F-VMAT心脏剂量最低但与深吸气屏气B-VMAT差异小。
  • B-VMAT显著降低乳腺V4,而深吸气屏气降低V10。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Radiotherapy is an effective treatment for mediastinal lymphoma but induces late effects including cardiac toxicity and secondary breast and lung cancer. Therefore reducing the dose to these organs is vital. We compared full arc volumetric modulated arc therapy (F-VMAT) against limited angle 'Butterfly' VMAT (B-VMAT) on free breathing (FB) and deep inspiration breath-hold (DIBH) computed tomography scans. The aim was to assess the benefits of B-VMAT over F-VMAT and to establish if the addition of DIBH results is a cumulative benefit. MATERIALS AND METHODS: F-VMAT and B-VMAT plans were calculated for 20 consecutive patients (15 females) with mediastinal lymphoma on both FB and DIBH scans. The planning target volume V95% was kept comparable between all plans while reducing organ doses as much as possible. RESULTS: B-VMAT significantly reduced low lung doses (V5-10), while F-VMAT was better for higher lung doses (V20-30). DIBH further improved lung doses for both types of plans. DIBH B-VMAT produced the lowest mean lung dose. With FB, heart doses were slightly higher for B-VMAT but the maximum difference was small (0.8% for V20) and only statistically significant for V10-20. The mean heart dose increased by only 0.1 Gy. The addition of DIBH however significantly reduced heart doses. While DIBH F-VMAT had the lowest heart doses, the difference was small compared with DIBH B-VMAT. B-VMAT significantly reduced breast V4 while DIBH reduced the V10. CONCLUSION: B-VMAT and DIBH are both effective in reducing organ doses and the dosimetric benefit is additive for some parameters and complementary for others.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Starke A, Bowden J, Lynn R, et al. Comparison of butterfly volumetric modulated arc therapy to full arc with or without deep inspiration breath hold for the treatment of mediastinal lymphoma. Radiother Oncol. 2018. PMID: 30245037. doi:10.1016/j.radonc.2018.08.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。